Dr. Krespi is a board certified otolaryngologist specializing in head and neck surgery at Northwell – Lenox Hill Hospital and Professor of Clinical Otolaryngology at Columbia University College of Physicians and Surgeons. Dr. Krespi graduated from medical school at Technion in Israel and completed his residency training at Mount Sinai Medical Center in New York. After his fellowship at Mount Sinai, he served as Associate Professor at Northwestern University Medical School in Chicago. He was Professor and Chairman of Otolaryngology at SUNY-Health Science Center in Brooklyn and Chairman at St. Lukes-Roosevelt Hospital. Dr. Krespi has published over 160 scientific medical articles, and has served as editor on four textbooks and written over 60 book chapters. He is one of the world’s leading experts in laser surgery, endoscopic sinus surgery, surgery to relieve snoring and sleep apnea, and oral malodor. Dr. Krespi is nationally and internationally recognized for his expertise and has received numerous awards and honors in his field.
Ron is an entrepreneurial, team-building executive with more than 35 years of experience in business, product and technology development, M&A, and general management of medical device and medical imaging companies in U.S. He is a leader with a proven ability to assess and identify new business, technology and market opportunities, and to conceive innovative corporate strategies. Ron held technical positions at Johnson & Johnson Ultrasound, and later co-founded and led for 10 years as the CEO of Ultrasound Technologies an OEM business that served all the major medical imaging companies. He sold the company to U.S. Surgical (Tyco/Covidien) where he continued as a Vice President. Following the acquisition of U.S. Surgical by Tyco, Ron acquired his division and sold it to the Charterhouse Group Int’l and served as the CEO of its U.S. based ultrasound company, Kntron Medical. In 2003 Ron joined Vision-Sciences, Inc. (NASDAQ: VSCI) as the company’s President and CEO and for seven years built the organization, lead the company’s innovation and development of its new lines of Urology, ENT, Pulmonology, upper GI and MIS Spine Surgery endoscopy products. Ron holds more than 15 patents in the fields of medical devices and medical imaging. In 2010 Ron founded NaNaMed, LLC and led the development of a unique colonoscopy product. In the recent years Ron has been involved in several start-up companies in various medical fields in Israel and the U.S. in executive positions and as board member/chairman.
Ron received his MSc. Degree in Computer Engineering from Polytechnic Institute of NY, (NYU), and his BSc. in Electrical Engineering from FDU.
Dr. Chandrasekhar, a fellowship trained Otologist/Neurotologist, received her undergraduate degree from Sophie Davis School of Biomedical Education, City College of New York, cum laude. She then went on to earn her M.D. at Mount Sinai School of Medicine. She completed her internship and residency in otolaryngology-head and neck surgery at New York University Medical Center, and her fellowship in otology/neurotology at the House Ear Clinic and Institute, in Los Angeles, California.
She has held leadership positions at the most prestigious organizations in her field, serving as President of the AAO-HNS where she was also Past Chair of their Board of Governors. She is currently Secretary/Treasurer of the American Otological Society, Vice President of the New York Otological Society, and Vice President-Elect of the Triological Society. Dr. Chandrasekhar is also a Clinical Professor of Otolaryngology, Zucker School of Medicine at Hofstra-Northwell, Clinical Associate Professor of Otolaryngology at Mount Sinai School of Medicine, Consulting Editor, Otolaryngology Clinics of North America, and Director of Neurotology, JJ Peters Veterans Affairs Medical Center.
Her honors and awards, foundation memberships, professional society participations, Grant activities, presentations and publications are extraordinarily numerous and laudable. Dr. Chandrasekhar is board certified as a Diplomate of the American Board of Otolaryngology in both Otolaryngology-Head and Neck Surgery and in Neurotology, and is licensed in New York and New Jersey.
CEO of Zelegent, Inc., a manufacturer of a novel device that enables sleep specialist otolaryngologists to perform a minimally-invasive procedure to alleviate snoring.
CFO of Carlsmed, Inc., a manufacturer of 3D-printed personalized spinal implants for lumbar fusion surgeries, and Protagenic Therapeutics, Inc, an early-stage biopharmaceutical company with a neuro-active peptide drug candidate.
Prior President, COO and Director at dental laser manufacturer Biolase, Inc.
Prior Chief Medical Officer of Stanford-affiliated neuroscience company Circuit Therapeutics.
Prior CFO of cardiovascular device manufacturer Arstasis, Inc.
Led medical technology equity research at Lazard.
MD from Harvard Medical School, BA, magna cum laude in Biophysics, Cornell University
David is an accomplished medical device executive with over 30 years experience in the ENT, Neurosurgery and Patient Handling markets. David held positions of increasing responsibility with Medtronic including VP ENT Sales, VP ENT Marketing and General Manager Global Service Solutions. At Medtronic David led the market research, development and successful launch of market leading sinus microdebrider, head and neck nerve monitoring, biofilm disruption, image guided surgery and obstructive sleep apnea technologies/ solutions. Additionally, David developed world class distribution, clinical education teams , facilities and programs that drove significant market share, customer loyalty, revenue and profits. David has a proven track record in P&L management, strategy, market segmentation, product development and talent acquisition/engagement. While at Stryker Corporation, David progressed through several commercial leadership assignments, many of the people, products and programs that he developed continue to yield significant results.
David received his BS Marketing from Indiana University, Bloomington Indiana and has completed executive programs at UCLA, The University of Michigan and The Gallup Organization.
Robert E. Grant is the Founder, Chairman, and Managing Partner of Strathspey Crown LLC, a growth equity holding company based in Newport Beach, CA with a broad portfolio of company and asset holdings spanning healthcare, clean energy, social media, and financial technology.
In addition, he is the Founder, Chairman and CEO of CONCIERGE KEY Health, the first on-demand service to the world’s elite physician specialists. He is also the Founder and Vice Chairman of ALPHAEON Corporation (a subsidiary of Strathspey Crown Holdings LLC), a leader in the rapidly growing field of Lifestyle Healthcare and based in Irvine, CA. He served as the founding CEO of CONCIERGE KEY Health from April, 2017 until July, 2018. Likewise, he served as the founding CEO of ALPHAEON Corporation from February, 2013 until August 2016.
He was formerly CEO and President of Bausch and Lomb Surgical in June of 2010. Prior to this, he led Allergan Medical as President from 2006 to 2010.
Robert has served on several corporate boards. He served as an independent Board Director at Myoscience, Inc., Acufocus, Inc. and ReShape Medical, Inc and presently serves on the boards of ALPHAEON Corporation and Zelegent, Inc. Additionally, he serves as Chairman and Founder of Crown Sterling Ltd, a Fintech/Cryptography subsidiary of Strathspey Crown LLC.
Additionally, he serves or has served on the boards of the following university and charitable organizations: The Schmid College of Chapman University, the University of California, Irvine (UCI) CEO Roundtable Steering Committee, The School of Law at UCI, The Henry Samueli School of Engineering, OCTANe (501-C3 non-profit entity) an economic development corporation for technology companies in Orange County, California where he served as Chairman of the Board of Directors, and the Young President’s Organization (YPO/WPO) Southern California Chapter where he currently serves as Chairman of the Board.
An accomplished sculptor, artist, and musician, Robert Grant additionally holds several patents and various intellectual property in the fields of DNA and phenotypic expression, human cybernetic implantology, biophotonics, and electromagnetism. He has multiple publications in unified mathematics and physics related to his discoveries of quasi-prime numbers (a new classification for prime numbers), the world’s first predictive algorithm determining infinite prime numbers, and a unification wave-based theory connecting and correlating fundamental mathematical constants such as Pi, Euler, Alpha, Gamma and Phi.
Robert holds a BA from Brigham Young University and an MBA (graduating with Honors) from Thunderbird, The American Graduate School of International Management. Additionally, he has attended the President’s Seminar at Harvard Business School (’09-’16). He has lived and worked in nine countries and speaks Japanese, French, Korean and German fluently.
• Sujana S. Chandrasekhar, MD, FACS
• Alejandro Berenstein, M.D.
• Gady Har-El, M.D.
• Michael Friedman, M.D.
• Paul Stoodley, PhD.
• Peter Costantino, M.D.
• Robert Lebovics, M.D.